Mechanistic Characterization of a Bacterial Terpene Synthase That Bifurcates to Produce Both 6/10- and 5/11-Bicyclic Diterpenes
Organic Letters · 12.11.2026
DOI: 10.1021/acs.orglett.6c04530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 12.11.2026. Verfasst von Wenbo Ning und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Gefördert von: NIH Office of the Director, National Institute of General Medical Sciences.
Abstract (Originalsprache)
The mechanism of the bacterial diterpene synthase ChtS from Chitinophaga japonensis was investigated. ChtS was found to produce two major diterpenes, 5/11-bicyclic chitino-2,5,9-triene (11), and the previously uncharacterized 6/10-bicyclic chitinoeunicellene (12). Deuterium labeling experiments, site-directed mutagenesis, and isolation of minor products cembrene C (13), cembrene A (14), and chitinol (15) support initial 1,14-cyclization, two sequential 1,2-hydride shifts, prior to bifurcation to 11 or 12, ultimately retaining the E-configured C-2/C-3 alkene.
Förderung
- NIH Office of the Director
- National Institute of General Medical Sciences
Zitieren
APA
Ning, W., Huang, P., Wei, X., Cavassa, F. G., Nafie, J., & Rudolf, J. D. (2026). Mechanistic Characterization of a Bacterial Terpene Synthase That Bifurcates to Produce Both 6/10- and 5/11-Bicyclic Diterpenes. Organic Letters. https://doi.org/10.1021/acs.orglett.6c04530
Vancouver
Ning W, Huang P, Wei X, Cavassa FG, Nafie J, Rudolf JD. Mechanistic Characterization of a Bacterial Terpene Synthase That Bifurcates to Produce Both 6/10- and 5/11-Bicyclic Diterpenes. Organic Letters. 2026. doi:10.1021/acs.orglett.6c04530
BibTeX
@article{Ning2026,
author = {Ning, Wenbo and Huang, Pin-Shuo and Wei, Xiuting and Cavassa, Fabrizio G. and Nafie, Jordan and Rudolf, Jeffrey D.},
title = {Mechanistic Characterization of a Bacterial Terpene Synthase That Bifurcates to Produce Both 6/10- and 5/11-Bicyclic Diterpenes},
journal = {Organic Letters},
year = {2026},
doi = {10.1021/acs.orglett.6c04530}
}
EUVIMED